Key facts
- PatenSee’s last known valuation is $7.5M (Feb 2025).
- It has raised $2.8M across 1 recorded rounds; the latest was Seed Round ($2.0M) in Feb 2025.
- Notable investors include Spark Capital, Innovation Authority, Michigan Rise, Intellectual Ventures, ARC Innovation Center — 10 tracked in total.
- PatenSee has filed 1 Form D with the SEC, most recently Feb 2025 ($1.6M sold to 10 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for PatenSee
Funding rounds
1 roundsAbout PatenSee
Developer of a contactless surveillance system designed to detect the early development of asymptomatic vascular stenosis in hemodialysis patients. The company's technology uses advanced, multi-modal imaging technologies and machine learning and is seamlessly integrated into the clinic workflow and detects early signs of vascular access stenosis to permit preventative and cost-effective intervention, enabling care teams to perform interventions to protect the patient's hemodialysis lifeline, improve quality of care and prolong life expectancy.
- Industry
- Monitoring Equipment
- Sector
- Healthcare
- HQ
- Or Yehuda, Israel
- Founded
- 2019
- Employees
- 9
- Website
- patensee.com/
- Ownership
- Privately Held (backing)
PatenSee doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PatenSee shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PatenSee in its N-PORT filings yet. We sweep new filings monthly.